Canada

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems seb_ra / iStock CIDRAP

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...

'The pandemic is not over': Experts expect a surge in COVID cases this fall | CBC News Higher COVID-19 levels seen in Ottawa in the past month are expected to continue to rise through the fall, public health experts warn. CBC

...

Ottawa's medical officer of health Vera Etches confirmed Thursday these trends will increase in the coming months, but said it's not yet clear that subvariants are driving the surge. 

Asthma-related ER visits in the US were 17% higher than expected during Canadian wildfires, new CDC study finds | CNN The wildfires in Canada, which caused smoke to blanket parts of the United States in recent months, have been linked to a significant rise in emergency hospital visits related to asthma. Jacqueline Howard CNN

...